Accessibility Statement Skip Navigation
  • Torna ai siti globali
  • +44 (0)20 7454 5110
  • GDPR
  • Giornalisti
  • Richiedi maggiori informazioni
PR Newswire: news distribution, targeting and monitoring
  • Notizie
  • Prodotti
  • Contatto
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Richiedi maggiori informazioni
      • Telefono

      • +44 (0)20 7454 5110 da 8 AM - 5 PM GMT

      • Contattaci
      • Contattaci

        +44 (0)20 7454 5110
        da 8 AM - 5 PM GMT

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • Notizie
    • Prodotti
    • Contatto
      • Richiedi maggiori informazioni
      • Giornalisti
      • GDPR
      • General Enquiries
      • Request a Demo
      • Editorial Bureaus
      • Partnership
      • Media Enquiries
      • Worldwide Offices
      • Richiedi maggiori informazioni
      • Giornalisti
      • GDPR

      Esaote Group: the Shareholders' Meeting approves the financial statements as at 31 December 2021, with consolidated turnover of 231.3 million euros (+5.3%) and an increase in net profit to 4 million euros.

      Esaote Logo

      Notizia fornita da

      Esaote S.p.A.

      29 apr, 2022, 11:00 GMT

      Condividi articolo

      Condividi articolo


      Operating income was 9.4 million euros (+2.9%) and the gross operating margin stood at 32.2 million euros.

      The total order book for magnetic resonance imaging and ultrasound rose by 19%.

      Esaote confirms its strong vocation for international markets (70%): growth was notable in North America, China, and Western Europe. Italy is the leading market.

      The headcount and investment in R&D are also rising.

      GENOA, Italy, April 29, 2022 /PRNewswire/ -- The Shareholders' Meeting of Esaote S.p.A., held on 29 April 2022 in Genoa, approved the company's financial statements as at 31.12.2021.

      The Group's consolidated turnover figures for the 2021 financial year indicate net sales revenue of 231.3 million euros, 5.3% up on 2020. The Group's operating income rose to 9.4 million euros, an increase of 2.9% year-on-year, and consolidated net profit reached 4 million euros (against 1 million euros in 2020). 

      Continue Reading
      Franco Fontana, CEO Esaote Group
      Franco Fontana, CEO Esaote Group

      "2021 was another extremely positive year for the Group, which achieved significant results in international markets and managed to combine growth with new investments. Compared to 2020, when the pandemic forced us into a sudden, significant review of our strategies, growth in 2021 was uniform in both lines of business and geographical regions," noted Franco Fontana, CEO of Esaote S.p.A.  "We have strengthened our leading position in the diagnostic imaging sector by expanding and renewing our offering, in line with the strategy of focusing on high-potential markets and continuing to bolster Research & Development: in 2021, we invested over 28 million euros in R&D, a 10% increase year-on-year. Growth in the order book of 19% on the previous year served as major confirmation that we are on the right track."

      In the ultrasound systems sector, revenue increased by approximately 5%, exceeding the overall trend in the world market. Specifically, an important point is Esaote's positive performance on strategic international markets, led by the new medium- to high-end mobile ultrasound scanners launched last year.

      Revenue in the dedicated open MRI sector increased by 39.8%. On the one hand, this remarkable result can be attributed to the post-pandemic recovery of the market; on the other, to Esaote's capability to offer products that are praised for excellent image quality in musculoskeletal applications, with low energy consumption: a good fit to meet emerging healthcare needs around the world. A further boost came from the introduction of Esaote's first open total body magnetic resonance scanner, granted EC MDR certification at year end.

      The line of business for dedicated diagnostic imaging software rose by 5.5%, specifically made possible by the success of our AI-based quantitative analysis programs. Further factors in this increase were the major boost provided by the digital transition focusing on the automation of hospital workflows, digital image archiving, and new teleconsultation and telemedicine applications. Finally, Global Service sales revenue increased by 6.3%.

      A major role in international markets, jointly accounting for approximately 70% of sales, was played by Western Europe (19.6%), North America (14%) and China (13%). Italy has been confirmed as the main market for Esaote. The Asia-Pacific, Latin America, Eastern Europe, and Middle East markets all grew by significant percentages. 

      At the end of 2021, the Group had 1,270 employees, more than half of whom were in Italy. Over 100 new hires took place over the year to renew the generational and professional mix, with a focus on the R&D, Sales, and Marketing departments. The average age of new hires was under 35, with 50% of them women. In 2021, Esaote launched its first Academy (e-Generation), a project in conjunction with the University of Genoa and seven higher education institutions in Tuscany, specifically for new graduates in the STEM subjects: following a selection process, 21 young talents were hired to the R&S, Information Technology and Global Marketing departments.

      Photo - https://mma.prnewswire.com/media/1807469/Esaote_Franco_Fontana.jpg
      Logo - https://mma.prnewswire.com/media/1793998/Esaote_Logo.jpg

      Modal title

      Also from this source

      MIDEA COMPLETA L'ACQUISIZIONE DI ESAOTE

      MIDEA COMPLETA L'ACQUISIZIONE DI ESAOTE

      Esaote S.p.A., leader nel settore dell'imaging medicale, annuncia il completamento dell'acquisizione della quota di controllo del capitale sociale...

      ECR 2026: Il Gruppo Esaote presenta innovazioni rivoluzionarie in Ultrasuoni, Risonanza Magnetica ed Enterprise Imaging

      ECR 2026: Il Gruppo Esaote presenta innovazioni rivoluzionarie in Ultrasuoni, Risonanza Magnetica ed Enterprise Imaging

      Il Gruppo Esaote, azienda italiana leader nell'innovazione dell'imaging medicale – ecografia, risonanza magnetica dedicata e IT medicale – partecipa...

      More Releases From This Source

      Contatta PR Newswire

      • +44 (0)20 7454 5110
        da 8 AM - 5 PM GMT

      Siti globali

      • APAC
      • APAC - Cinese tradizionale
      • Asia
      • Brasile
      • Canada
      • Ceco
      • Danimarca
      • Finlandia
      • Francia
      • Germania

       

      • India
      • Indonesia
      • Israele
      • Italia
      • Messico
      • Medio Oriente
      • Medio Oriente - Arabo
      • Olanda
      • Norvegia
      • Polonia

       

      • Portogallo
      • Russia
      • Slovacchia
      • Spagna
      • Svezia
      • Regno Unito
      • Stati Uniti

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921
      Siti globali
      • Asia
      • Brasile
      • Canada
      • Ceco
      • Danimarca
      • Finlandia
      • Francia
      • Germania
      • India
      • Israele
      • Italia
      • Messico
      • Medio Oriente
      • Olanda
      • Norvegia
      • Polonia
      • Portogallo
      • Russia
      • Slovacchia
      • Spagna
      • Svezia
      • Regno Uniti
      • Stati Uniti
      +44 (0)20 7454 5110
      da 8 AM - 5 PM GMT
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • Cookie Settings
      Copyright © 2026 Cision US Inc.